← All articles

Total current articles · 5,244

Beth Israel Deaconess Medical Center

Published

01In brief

Beth Israel Deaconess Medical Center (BIDMC) is a Harvard-affiliated academic medical center in Boston, Massachusetts, and part of Beth Israel Lahey Health. It treated victims of the Boston Marathon bombing and was among the hospitals within a mile or two of the bombed area. Created in 1996 through the merger of Beth Israel Hospital and New England Deaconess Hospital, it brings together institutions whose histories include Jewish communal philanthropy, service to underserved patients, and advances in diabetes treatment, cardiac care, surgery, and medical computing. Its East and West campuses are in Boston’s Longwood Medical and Academic Area.

02Overview and Location

BIDMC combines patient care with medical education and research, with affiliations that include Harvard Medical School and Dana-Farber Cancer Institute.[1] Its two predecessor hospitals developed distinct traditions of care: Beth Israel emerged from Boston’s Jewish community, while New England Deaconess originated in the work of Methodist deaconesses caring for underserved people.[6][7] The institutions merged in 1996, and BIDMC later became one of the founding hospitals of Beth Israel Lahey Health when that system launched in 2019.[4]

The medical center’s main address is 330 Brookline Avenue, Boston, Massachusetts.[5] Its East and West campuses occupy interconnected sites in the Longwood Medical and Academic Area; a third-floor skybridge provides access between patient-care areas in West Campus buildings.[5] Beth Israel Hospital’s move to Brookline Avenue in 1928 brought it closer both to Harvard Medical School and to Jewish population centers in Brookline and Newton.[6]

The institution’s formal name is Beth Israel Deaconess Medical Center, with BIDMC and B.I.D.M.C. recorded as abbreviated variants.[8] The medical center reports 766 licensed beds and substantial inpatient, emergency, maternity, and outpatient activity.[1]

03History

Boston’s Jewish community established the Jewish Dispensary for Men and Women in the North End in 1892, when many of the city’s Jews lived there.[6] Patients sought Jewish medical institutions partly because general hospitals felt unfamiliar and because they wanted caregivers with whom they could communicate more easily.[6] These efforts developed within a wider network of Jewish philanthropy that included the United Hebrew Benevolent Association, founded in 1864, the Hebrew Industrial School, and the Hebrew Sheltering Home.[9] As charitable needs exceeded available funds, the Federation of Jewish Charities of Boston was formed in 1895.[9]

Mount Sinai Hospital was established in Boston’s West End in 1902 as an outpatient clinic, although its founding encountered considerable opposition within parts of the Jewish community.[9] It had 36 accredited physicians and two clinics serving different parts of the city.[6] Patient numbers rose from 11,000 in 1908 to more than 24,000 in 1913, overwhelming the institution; city authorities condemned its building in 1913.[6]

A group of North End women began discussing a new hospital in 1909 because Mount Sinai could not meet demand.[6] Their fundraising began with collections of pennies, and in 1911 they organized the Beth Israel Hospital Association, which was incorporated in 1915.[6] The association bought a site in Roxbury in 1916 and built the hospital that replaced Mount Sinai.[6] Beth Israel Hospital was dedicated on Townsend Street in 1916 with 45 beds, and it replaced Mount Sinai in 1917.[4][9]

Beth Israel belonged to a wider American tradition of Jewish-sponsored hospitals, whose early purposes included providing patients with a medical environment they regarded as Jewish.[10] Some East European immigrants objected to the atmosphere of established hospitals, while after about 1920 Jewish hospitals increasingly provided professional opportunities for Jewish physicians facing discrimination in staff appointments elsewhere.[10] Beth Israel’s later institutional mission explicitly included care for sick and disabled people of any race, creed, color, or nationality.[11]

New England Deaconess Hospital opened in 1896 in a residential brownstone on Massachusetts Avenue, initially with 14 beds.[4] Its founders were deaconesses who worked full-time for Methodist churches and sought to care for underserved people.[7] The nursing school graduated its first class in 1898: three nurses, all deaconesses.[4] Later graduates developed particular expertise in diabetes and surgical nursing.[4]

In 1907, New England Deaconess moved to the Longwood area and built the 50-bed Deaconess Building.[4] Frank H. Lahey, a specialist in goiter and thyroid conditions, joined its surgical staff in 1914; he later formed Lahey Clinic and pioneered multispecialty group medical practice.[4] In 1915, the hospital’s Brodbeck Cottage became a center for diabetes treatment and teaching through a partnership with Elliott P. Joslin, with nurses receiving specialized training in diabetic care.[4]

Under Joslin’s supervision, Howard Root administered the first insulin treatment in the United States at New England Deaconess in 1922.[4] The hospital opened a cancer-care facility in 1927, creating one of the area’s largest programs for treating and researching cancer and other diseases then considered incurable.[4] In 1933, its physician Richard Overholt performed the world’s first successful removal of a right lung from a patient with cancer.[4] Overholt also became an early opponent of smoking and later persuaded the hospital to establish smoke-free areas on patient floors.[4]

Beth Israel moved to its Brookline Avenue facility in 1928 and established a teaching and research partnership with Harvard Medical School that year.[4] Herrman Blumgart directed medical research and headed the Harvard Teaching Service.[4] The relocation placed the hospital nearer the Jewish communities of Brookline and Newton as well as Harvard’s medical school.[6]

During World War II, physicians, nurses, and other employees from both hospitals left for national service, requiring junior staff to assume major responsibilities.[4] Volunteers helped fill staffing gaps, including the Gray Ladies, the Red Cross, and the Male Volunteer Corps.[4] In 1945, New England Deaconess pathologist Shields Warren led the first comprehensive study of radioactive fallout’s effects on humans after the atomic bombings of Hiroshima and Nagasaki.[4] He subsequently became the first director of the U.S. Atomic Energy Commission’s Division of Biology and Medicine.[4]

New England Deaconess established the Cancer Research Institute in 1951, the first New England research facility devoted solely to cancer.[4] At Beth Israel in 1952, Paul Zoll and his team developed the transthoracic pacer, a noninvasive means of restarting the heart.[4] In 1959, research led by hematologist James Tullis made New England Deaconess the first hospital in the United States to bank blood platelets for immediate transfusion.[4]

Beth Israel established its Division of Clinical Informatics in 1970, developing electronic hospital data systems under Warner Slack and Howard Bleich.[4] Two years later, under president Mitchell Rabkin, the hospital created a Patient Bill of Rights that became a model for Massachusetts legislation enacted in 1979.[4] New England Deaconess became an official member of the Harvard Medical School community in 1973 when it joined the Harvard Surgical Service.[4]

Social worker Frances Addelson, who began working at Beth Israel in 1954, recalled that around 1970 the hospital arranged psychiatric interviews for women seeking abortions while she collected their social histories.[12] Her oral-history account described demand exceeding the hospital’s capacity and disagreement among some physicians and trustees over the program.[12]

In 1983, a New England Deaconess team led by Roger Jenkins performed New England’s first successful liver transplant.[4] That same year, Beth Israel pathologist Harold Dvorak’s laboratory identified vascular permeability factor, a protein enabling blood-vessel growth.[4] The discovery contributed to the development of angiogenesis research and approaches to cancer treatment that deprive tumors of their blood supply.[4] Beth Israel physicians and scientists also contributed to Massachusetts’ first birth following in-vitro fertilization; the baby was born at the hospital on July 23, 1984.[4]

Both hospitals became smoke-free in 1991.[4] Beth Israel expanded beyond its main campus in 1993 by opening the Medical Care Center in Lexington, its first community-based outpatient specialty-care facility.[4] A Chelsea facility followed in 1995, with later specialty-care expansion into Chestnut Hill.[4]

Beth Israel Hospital and New England Deaconess Hospital merged in 1996 to form Beth Israel Deaconess Medical Center.[4][8] The merger was one example of a broader transformation in American Jewish-sponsored hospitals: of 33 Jewish-sponsored acute-care general hospitals operating in 1975, fewer than half remained under their original ownership or sponsorship by late 1999, and 13 had formed or joined partnerships with other facilities.[10] Also in 1996, BIDMC opened the Carl J. Shapiro Clinical Center on the former site of Massachusetts College of Art.[4]

Research milestones continued after the merger.[4] In 1996, scientist Kun Ping Lu discovered Pin 1, an enzyme associated with protection against Alzheimer’s disease; this work contributed to subsequent efforts to develop antibody therapies for Alzheimer’s disease and traumatic brain injury.[4] In 1998, BIDMC performed New England’s first adult-to-adult living-donor liver transplant.[4]

The medical center launched PatientSite, a secure patient portal, in 2000.[4] It adopted OpenNotes in 2010, allowing patients to read their doctors’ notes through the portal.[4] In 2011, its webOMR electronic health record became the first hospital electronic health record system in the country certified for meaningful use under Medicare and Medicaid.[4]

Victims of the 2013 Boston Marathon explosions received treatment at BIDMC.[3] The hospital was among a group of major hospitals situated within a mile or two of the bombed area, enabling victims to reach nearby medical facilities.[2] The two suspected bombers were subsequently admitted separately to BIDMC’s emergency room after being wounded in a police shootout.[3]

BIDMC became a founding hospital of Beth Israel Lahey Health in 2019.[4] During the COVID-19 pandemic, it became the first Massachusetts hospital to offer high-capacity, in-house COVID-19 testing in 2020.[4] In 2021, a vaccine developed through research led by BIDMC’s Dan Barouch in collaboration with Johnson & Johnson received U.S. Food and Drug Administration Emergency Use Authorization.[4]

04Demographics and Patient Services

BIDMC reports more than 39,000 inpatient discharges, more than 55,000 emergency department visits, more than 760,000 outpatient visits, and more than 4,600 births, alongside its 766 licensed beds.[1] These figures describe the merged medical center, rather than the smaller Beth Israel Hospital documented before the 1996 merger.[1][11]

In 1990, Beth Israel Hospital was licensed for 504 beds and 80 newborn bassinets.[11] Its reported annual activity included approximately 24,000 inpatients, 6,500 deliveries, 40,000 visits to its round-the-clock emergency unit, and more than 200,000 outpatient visits.[11] These are historical figures from the predecessor hospital, not current totals for BIDMC.[11]

Beth Israel served Boston and nearby communities including Mission Hill, the Fenway, Roxbury, and Brookline.[11] Boston residents accounted for more than one-third of its inpatient admissions in the 1990 planning figures.[11] The hospital combined community-hospital services with referral care for complex cases, emphasizing personalized care alongside technically advanced treatment.[11]

05Economy and Culture

Beth Israel Hospital employed approximately 5,000 people in 1990, of whom 41% lived in Boston.[11] Its estimated annual economic impact through payroll and purchasing exceeded $260 million at that time.[11] Its institutional mission joined patient care with education, philanthropy, and research, treating teaching and research as integral to clinical work.[11]

Harvard medical education was a substantial part of the hospital’s activity before the merger.[11] In 1990, Beth Israel staff provided approximately 20% of Harvard Medical School students’ clinical instruction.[11] The hospital had eight accredited residency programs, with 54 interns and 157 residents, and conducted extensive medical research.[11] BIDMC’s stated affiliations now include Harvard Medical School, Dana-Farber Cancer Institute, and the Boston Red Sox.[1]

Medical computing has also connected the institution’s work with international disaster response.[13] John Halamka, identified in 2012 as BIDMC’s chief information officer, worked in Japan on health-care information technology supporting earthquake and tsunami response.[13] His blog discussed that work as part of its coverage of health-care technology.[13]

Telehealth research associated with BIDMC has examined quality, spending, and access to care.[14] In prepared Senate testimony, BIDMC physician and Harvard Medical School professor Ateev Mehrotra described research involving stroke, mental illness, substance-use disorders, contraception, and acute respiratory illness.[14]

The medical center has personnel and research connections with Israel.[3][15] At the time of the 2013 Marathon attacks, chief executive Kevin (Ilan) Tabb had held his position since September 2011.[3] Born in the United States, he moved to Israel at 18, served in the Israel Defense Forces, studied at Hebrew University, and completed an internal-medicine residency at Hadassah Medical Center.[3]

Daniel S. Talmor, then a director of trauma, anesthesia, and critical care, was born in Jerusalem and graduated from Ben-Gurion University of the Negev’s medical program in 1991.[3] Before joining Beth Israel Deaconess, he worked at Soroka Medical Center.[3] Both men were among the Israeli-connected physicians and leaders at the institution during its response to the Marathon bombings.[3]

In 2020, BIDMC partnered with the Israeli company XRHealth on a project supported by the Israel-U.S. Binational Industrial Research and Development Foundation.[15] The project sought to develop a perioperative virtual-reality platform intended to distract patients from pain during medical procedures.[15] A separate 2026 report identified startup Ozz Health as conducting research with the emergency department of Beth Israel Hospital in Boston, without specifying the protocol or connecting it to the XRHealth project.[16]

06Notable Sites

The Carl J. Shapiro Clinical Center opened in 1996, the year of the merger, on the former Massachusetts College of Art site.[4] The Klarman Building opened in 2023 as BIDMC’s first new building in 27 years.[4] It added 158 single-bed, family-friendly patient rooms and procedural suites.[4]

Earlier facilities associated with the predecessor hospitals included the Deaconess Building, a 50-bed Longwood facility constructed in 1907, and Brodbeck Cottage, which became a diabetes-care and teaching site in 1915.[4] Beth Israel’s Brookline Avenue hospital, built in 1928, established the location from which it developed its Harvard teaching and research partnership.[4]

Sources

  1. 1Beth Israel Deaconess Medical Center, About BIDMC, accessed on November 20, 2026.
  2. 2International Institute for Counter-Terrorism, Opinion: Preparing for the next one, accessed on November 20, 2026.
  3. 3Jewish News Syndicate, Boston Marathon explosions' victims and suspects alike treated by Israeli doctors, accessed on November 20, 2026.
  4. 4Beth Israel Deaconess Medical Center, History, accessed on November 20, 2026.
  5. 5Beth Israel Deaconess Medical Center, BIDMC Location, accessed on November 20, 2026.
  6. 6Berman Jewish Policy Archive, Where It All Began (1976), accessed on November 20, 2026.
  7. 7Beth Israel Deaconess Medical Center, Medicine Department, accessed on November 20, 2026.
  8. 8Library of Congress, Beth Israel Deaconess Medical Center Authority Record, accessed on November 20, 2026.
  9. 9Jewish Virtual Library, Boston, Massachusetts, accessed on November 20, 2026.
  10. 10Encyclopedia.com, Hospitals, accessed on November 20, 2026.
  11. 11Internet Archive, Beth Israel Hospital, Master Plan 1990–1995, accessed on November 20, 2026.
  12. 12Jewish Women's Archive, Frances Addelson Transcript, accessed on November 20, 2026.
  13. 13Library of Congress, Developing a Health and Medicine Blogs Collection at the U.S. National Library of Medicine | The Signal, accessed on November 20, 2026.
  14. 14Congress.gov, U.S. Senate Hearing Transcript, accessed on November 20, 2026.
  15. 15CTech by Calcalist, Israel-U.S. BIRD Foundation invests $8 million in 10 new collaborations, accessed on November 20, 2026.
  16. 16CTech by Calcalist, An unlikely AI founder is trying to fix one of medicine’s most human problems, accessed on November 20, 2026.

IsraelPedia Question & Answers

  • What is Beth Israel Deaconess Medical Center?

    Beth Israel Deaconess Medical Center (BIDMC) is a Harvard-affiliated academic medical center in Boston, Massachusetts, and part of Beth Israel Lahey Health. Formed in 1996 through the merger of Beth Israel Hospital and New England Deaconess Hospital, it combines patient care, medical education, and research. Its East and West campuses are in Boston’s Longwood Medical and Academic Area.

  • How did Beth Israel Deaconess Medical Center form?

    Beth Israel Deaconess Medical Center formed in 1996 when Beth Israel Hospital and New England Deaconess Hospital merged. Beth Israel Hospital grew from Boston’s Jewish community, while New England Deaconess Hospital was founded by Methodist deaconesses to care for underserved people. BIDMC became a founding hospital of Beth Israel Lahey Health in 2019.

  • What medical advances are associated with Beth Israel Deaconess Medical Center and its predecessor hospitals?

    The predecessor hospitals and BIDMC contributed to advances in diabetes care, cardiac treatment, surgery, and medical computing. New England Deaconess administered the first insulin treatment in the United States in 1922, and Beth Israel developed the transthoracic pacer in 1952. Later milestones included New England’s first successful liver transplant in 1983 and BIDMC’s first adult-to-adult living-donor liver transplant in New England in 1998.

  • What happened at Beth Israel Deaconess Medical Center during the 2013 Boston Marathon bombings?

    Beth Israel Deaconess Medical Center treated victims of the 2013 Boston Marathon explosions. It was among the major hospitals within a mile or two of the bombed area, allowing victims to reach nearby medical facilities. The two suspected bombers were later admitted separately to BIDMC’s emergency room after being wounded in a police shootout.

  • What patient services and capacity does Beth Israel Deaconess Medical Center report?

    Beth Israel Deaconess Medical Center reports 766 licensed beds, more than 39,000 inpatient discharges, more than 55,000 emergency department visits, more than 760,000 outpatient visits, and more than 4,600 births. These figures describe the merged medical center, rather than the smaller Beth Israel Hospital before the 1996 merger.

  • What are the major buildings at Beth Israel Deaconess Medical Center?

    The Carl J. Shapiro Clinical Center opened in 1996 on the former site of Massachusetts College of Art. BIDMC’s Klarman Building opened in 2023 as its first new building in 27 years, adding 158 single-bed, family-friendly patient rooms and procedural suites. The medical center’s East and West campuses are interconnected in the Longwood Medical and Academic Area.

  • What is Beth Israel Deaconess Medical Center’s connection to Israel?

    Beth Israel Deaconess Medical Center has personnel and research connections with Israel. Its leaders Kevin (Ilan) Tabb and Daniel S. Talmor had ties to Israel through their backgrounds, education, or medical work. In 2020, BIDMC also partnered with Israeli company XRHealth on a project to develop a virtual-reality platform intended to distract patients from pain during medical procedures.